AI assistant
Sending…
REGENXBIO Inc. — Director's Dealing 2015
Sep 17, 2015
32827_dirs_2015-09-17_cea4f514-1d87-4e55-8ce1-ba04f9ee8ae1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENXBIO Inc. (RGNX)
CIK: 0001590877
Period of Report: 2015-09-16
Reporting Person: ENGLEMAN EDGAR (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-09-16 | Stock Option (Right to Buy) | $22.00 | A | 25000 | Acquired | 2025-09-16 | Common Stock (25000) | Direct |
Footnotes
F1: The option will vest in equal monthly installments over the 12 months following September 16, 2015, with immediate full vesting in the event of a change in control.
More from REGENXBIO Inc.
Merger & Acquisition
2026
Jun 3
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Proxy Solicitation & Information Statement
2026
Apr 14
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Feb 10
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Jan 29